Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02788279 | A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370) | completed | Phase 3 | 363 | Hoffmann-La RocheINDUSTRY | 11 | Dec 11, 2019 | clinicaltrials |
| NCT02251977 | Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer | completed | Phase 3 | 196 | Yuhong LiOTHER | 1 | Oct 7, 2019 | clinicaltrials |
| NCT01183780 | A Study in Second Line Metastatic Colorectal Cancer | completed | Phase 3 | 1,072 | Eli Lilly and CompanyINDUSTRY | 26 | Sep 25, 2019 | clinicaltrials |
| NCT00096278 | Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer | completed | Phase 3 | 2,710 | National Cancer Institute (NCI)NIH | 1 | Jul 30, 2019 | clinicaltrials |
| NCT02332499 | Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703)(ALTER0703) | completed | Phase 2 / Phase 3 | 419 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | May 21, 2019 | clinicaltrials |
| NCT00238381 | Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer | completed | Phase 3 | 336 | Swiss Cancer InstituteOTHER | 2 | May 15, 2019 | clinicaltrials |
| NCT01640405 | Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells(VISNU-1) | completed | Phase 3 | 350 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Apr 11, 2019 | clinicaltrials |
| NCT01550055 | Study of CMAB009 to Treat KRAS Wild Type Metastatic Colorectal Cancer(CRC009) | completed | Phase 2 / Phase 3 | 512 | Shanghai Zhangjiang Biotechnology Limited CompanyINDUSTRY | 0 | Apr 10, 2019 | clinicaltrials |
| NCT00252564 | Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer | completed | Phase 3 | 247 | US Oncology ResearchINDUSTRY | 1 | Feb 15, 2019 | clinicaltrials |
| NCT03350490 | Bioinformation Therapy for Intestinal Cancer | completed | Phase 2 / Phase 3 | 120 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT00068692 | Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer | completed | Phase 3 | 225 | National Cancer Institute (NCI)NIH | 1 | Dec 4, 2018 | clinicaltrials |
| NCT01651949 | Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) | completed | Phase 3 | 2,520 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 27, 2018 | clinicaltrials |
| NCT00115765 | PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study | completed | Phase 3 | 1,053 | AmgenINDUSTRY | 0 | Oct 17, 2018 | clinicaltrials |
| NCT00032344 | Long-term Follow-up Study Designed to Evaluate the Relative Risk of Two Colonoscopy Schedules for Patients With Small Polyps | completed | Phase 3 | 3,200 | US Department of Veterans AffairsFED | 1 | Aug 31, 2018 | clinicaltrials |
| NCT00749450 | Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer | completed | Phase 3 | 6,088 | Cancer Research UK, GlasgowOTHER | 1 | Jul 27, 2018 | clinicaltrials |
| NCT02127645 | Neoadjuvant Radiotherapy Followed by Transanal Endoscopic Microsurgery for T1-T2 Extraperitoneal Rectal Cancer(NERATEM) | completed | Phase 3 | 25 | European Association for Endoscopic SurgeryOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT02706184 | E. Coli Nissle in Oncology(EcNO) | completed | Phase 3 | 20 | University of HohenheimOTHER | 1 | May 15, 2018 | clinicaltrials |
| NCT02284139 | Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects | completed | Phase 2 / Phase 3 | 90 | Dong-A University HospitalOTHER | 1 | Apr 23, 2018 | clinicaltrials |
| NCT00758186 | Randomized Trial of Colonic Stents as a Bridge to Surgery | completed | Phase 3 | 40 | Singapore General HospitalOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT01918852 | S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.(SALTO) | completed | Phase 3 | 161 | Dutch Colorectal Cancer GroupOTHER | 1 | Mar 14, 2018 | clinicaltrials |
| NCT00911170 | PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study | completed | Phase 3 | 847 | AmgenINDUSTRY | 17 | Dec 29, 2017 | clinicaltrials |
| NCT03362684 | PETACC-8 miR-31-3p and miR-31-5p Ancillary Study | completed | Phase 3 | 1,808 | IntegraGen SAINDUSTRY | 0 | Dec 5, 2017 | clinicaltrials |
| NCT01694966 | The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy | completed | Phase 3 | 1,249 | Cosmo Technologies LtdINDUSTRY | 8 | Nov 6, 2017 | clinicaltrials |
| NCT00687830 | Efficacy of Morning-only Bowel Preparation for Afternoon Colonoscopy.(CCF) | completed | Phase 3 | 136 | Cleveland Clinic FloridaOTHER | 1 | May 17, 2017 | clinicaltrials |
| NCT00509444 | Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial(CPTD) | completed | Phase 3 | 200 | Johns Hopkins Bloomberg School of Public HealthOTHER | 1 | Apr 20, 2017 | clinicaltrials |
| NCT00384176 | First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX(HORIZON III) | completed | Phase 2 / Phase 3 | 1,814 | AstraZenecaINDUSTRY | 28 | Apr 14, 2017 | clinicaltrials |
| NCT01523431 | Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients | completed | Phase 2 / Phase 3 | 583 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Mar 30, 2017 | clinicaltrials |
| NCT00153816 | Vitamin D/Calcium Polyp Prevention Study | completed | Phase 2 / Phase 3 | 2,813 | Dartmouth-Hitchcock Medical CenterOTHER | 2 | Mar 15, 2017 | clinicaltrials |
| NCT01412957 | Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 377 | AmgenINDUSTRY | 16 | Mar 15, 2017 | clinicaltrials |
| NCT01786694 | Feasibility of Microdialysis by Laparoscopy(MTM-COLON-I) | completed | Phase 3 | 11 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Feb 1, 2017 | clinicaltrials |
| NCT00003596 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | completed | Phase 3 | 682 | Radiation Therapy Oncology GroupNETWORK | 2 | Jan 4, 2017 | clinicaltrials |
| NCT00399035 | Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer(HORIZON II) | completed | Phase 3 | 1,254 | AstraZenecaINDUSTRY | 15 | Dec 28, 2016 | clinicaltrials |
| NCT01169558 | A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum. | completed | Phase 3 | 168 | Hoffmann-La RocheINDUSTRY | 1 | Dec 8, 2016 | clinicaltrials |
| NCT00766155 | Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer(PETACC-6) | completed | Phase 3 | 1,094 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Oct 12, 2016 | clinicaltrials |
| NCT01372007 | Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma | completed | Phase 3 | 24 | University Hospital, GhentOTHER | 1 | Oct 7, 2016 | clinicaltrials |
| NCT00069095 | A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 2,035 | Hoffmann-La RocheINDUSTRY | 33 | Oct 6, 2016 | clinicaltrials |
| NCT00392899 | Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery | completed | Phase 3 | 2,025 | Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanOTHER | 1 | Sep 28, 2016 | clinicaltrials |
| NCT00147134 | A Trial to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer | completed | Phase 3 | 1,050 | Haruhiko FukudaOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT00002523 | Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed | completed | Phase 3 | 1,011 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Sep 2, 2016 | clinicaltrials |
| NCT00316914 | Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery | completed | Phase 3 | 104 | Alliance for Clinical Trials in OncologyOTHER | 1 | Aug 11, 2016 | clinicaltrials |
| NCT00660894 | Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery | completed | Phase 3 | 1,535 | Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT00002575 | Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer | completed | Phase 3 | 810 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 18, 2016 | clinicaltrials |
| NCT00002716 | Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | completed | Phase 3 | 135 | Alliance for Clinical Trials in OncologyOTHER | 4 | Jul 13, 2016 | clinicaltrials |
| NCT00003600 | Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy | completed | Phase 3 | 344 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00003674 | Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer | completed | Phase 3 | 141 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00026117 | Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer | completed | Phase 3 | 88 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Dec 11, 2019source: clinicaltrials